The benefits are worth investment

Retired surgeon Robert Bernhoft’s letter (“Put money where it will do most good,” Oct. 15) offers little medical reality. He claims that adult stem cells can be changed into practically any tissue. In reality, the adult stem cell taken from mature tissue can renew itself but has limited ability to transform into specialized cell types.

Production of large numbers of adult cells is much more difficult than the case for embryonic cells. Based upon present knowledge, it appears unlikely human adult stem cells alone will provide all the necessary cell types required for the most important areas of research.

Adult stem cells are multipotent; the number of tissues that they can regenerate compares poorly with the pluripotency of embryonic stem cells and embryonic germ cells. Adult stem cells are capable of differentiating into bone, cartilage, muscle, fat, and a few other tissue types. Adult-derived stem cell therapies will complement, but cannot replace, therapies that may be eventually obtained from embryonic cells.

The use of embryonic stem cells for therapeutic cloning (SCNT) holds great promise for treating and curing patients by creating tailor-made, genetically identical cells that their bodies won’t reject, eliminating the need for lifelong immunosuppressing drugs. Proof of principle for SCNT has been established in published research (March 2002 issue of “Cell”).

Consider that one in three children born today will develop diabetes and that embryonic stem cell research may find a cure for diabetes. Then contemplate the hopeful 134 million U.S. patients who are currently awaiting stem cell based therapies. Moreover, think of how much money would be saved each year if stem cell research finds cures for diseases like diabetes, Parkinson’s, cardiovascular disease and many others. We must invest in the future of stem cell therapies so that many will have a future.

Pat Kessler

Mukilteo

Talk to us

> Give us your news tips.

> Send us a letter to the editor.

> More Herald contact information.

More in Opinion

RGB version
Editorial cartoons for Saturday, April 26

A sketchy look at the news of the day.… Continue reading

County Council members Jared Mead, left, and Nate Nehring speak to students on Thursday, Jan. 30, 2025, during Civic Education Day at the Snohomish County Campus in Everett, Washington. (Will Geschke / The Herald)
Editorial: Students get a life lesson in building bridges

Two county officials’ civics campaign is showing the possibilities of discourse and government.

Roberts: Gutting of scientific research will leave us blind

The Trump administration’s deep cuts to science and research will harm our economy and environment.

Comment: Funding delays jeopardize research of healthy aging

A freeze of NIH funding threatens research into aging and Alzheimer’s at the UW School of Medicine.

Comment: Meaningful law on rent requires bill’s earlier version

As lawmakers seek a deal, rent stabilization should keep a 7 percent cap and apply to single homes.

Forum: Trump cuts to museum funding hit Imagine Children’s

The defunding of a museum and library program means the loss of a science lab for preschoolers.

Forum: We strive for Belonging, then keep it to ourselves

From childhood we treat Belonging as something to be jealously guarded. What if others belong, too?

Comment: Higher tax on tobacco pouches could backfire

A proposed 95 percent tax on smokeless tobacco could lead some back to more dangerous cigarettes.

toon
Editorial cartoons for Friday, April 25

A sketchy look at the news of the day.… Continue reading

FILE - This Feb. 6, 2015, file photo, shows a measles, mumps and rubella vaccine on a countertop at a pediatrics clinic in Greenbrae, Calif. Washington state lawmakers voted Tuesday, April 23, 2019 to remove parents' ability to claim a personal or philosophical exemption from vaccinating their children for measles, although medical and religious exemptions will remain. (AP Photo/Eric Risberg, File)
Editorial: Commonsense best shot at avoiding measles epidemic

Without vaccination, misinformation, hesitancy and disease could combine for a deadly epidemic.

The Buzz: This week, the makeup tips of political powerbrokers

Who would have guessed that Kitara Revanche and Pete Hegseth used the same brand of concealer?

Schwab: Who saw this coming? said no one but Senate Republicans

Take your pick of agency heads; for those who advise and consent, there was no sign of trouble ahead.

Support local journalism

If you value local news, make a gift now to support the trusted journalism you get in The Daily Herald. Donations processed in this system are not tax deductible.